Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer
Por:
Di Cosimo S, Perez-Garcia J, Bellet M, Dalenc F, Gil M, Ruiz-Borrego M, Gavila J, Aguirre E, Schmid P, Marme F, Gligorov J, Schneeweiss A, Albanell J, Zamora P, Wheatley D, de Duenas E, Amillano K, Shimizu E, Sampayo-Cordero M, Cortes J, Llombart-Cussac A
Publicada:
1 ago 2024
Ahead of Print:
1 jun 2024
Resumen:
|